Ernexa Therapeutics Inc.

ERNA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$3,047$4,315$1,918$1,729
Short-Term Investments$0$0$0$0
Receivables$0$154$156$437
Inventory$0$0$0$0
Other Curr. Assets$332$323$137$186
Total Curr. Assets$3,379$4,792$2,211$2,352
Property Plant & Equip (Net)$633$631$686$755
Goodwill$2,044$2,044$2,044$2,044
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$116$117$118$118
Total NC Assets$2,793$2,792$2,848$2,917
Other Assets$0$0$0$0
Total Assets$6,172$7,584$5,059$5,269
Liabilities
Payables$958$1,319$1,275$1,721
Short-Term Debt$206$217$2,463$207
Tax Payable$0$11$11$3
Deferred Revenue$0$0$0$0
Other Curr. Liab.$980$1,104$6,689$1,007
Total Curr. Liab.$2,144$2,651$10,438$2,938
LT Debt$346$376$419$477
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$112$113$152$153
Total NC Liab.$458$489$571$630
Other Liabilities$0$0$0$0
Cap. Leases$552$593$632$477
Total Liabilities$2,602$3,140$11,009$3,568
Equity
Pref Stock$1$1$1$1
Common Stock$39$37$262$257
Retained Earnings-$244,126-$242,885-$239,738-$231,536
AOCI$0$0$0$0
Other Equity$247,656$247,291$233,525$232,979
Total Equity$3,570$4,444-$5,950$1,701
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$6,172$7,584$5,059$5,269
Net Debt-$2,495-$3,722$964-$1,045
Ernexa Therapeutics Inc. (ERNA) Financial Statements & Key Stats | AlphaPilot